West Pharma (WST) Tops Q2 EPS by 34c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
BofA Securities Upgrades West Pharmaceutical (WST) to Buy
July 21, 2020 9:17 AM EDTBofA Securities upgraded West Pharmaceutical (NYSE: WST) from Neutral to Buy.
For an analyst ratings summary and ratings history on West Pharmaceutical click here. For more ratings news on West Pharmaceutical click here.
Shares of West Pharmaceutical closed at $255.23 yesterday.
... MoreBofA Securities Upgrades West Pharmaceutical (WST) to Buy
July 21, 2020 7:08 AM EDTBofA Securities upgraded West Pharmaceutical (NYSE: WST) from Neutral to Buy.
For an analyst ratings summary and ratings history on West Pharmaceutical click here. For more ratings news on West Pharmaceutical click here.
Shares of West Pharmaceutical closed at $251.84 yesterday.
... More


